You can copy/paste HTML codes anywhere you like, for example in homepage, or even other sites

XML SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development
Mahboubeh Zarei, Alireza Zakeri, Saeed Khalili *, Zahra Sadat Hashemi
Abstract -   Full Text (PDF)
XML Novel Protein Expression and Purification of SARS CoV-2 from Recombinant Escherichia coli System
Maryam Mashhadi Abolghasem Shirazi, Mina Hannan, Golnaz Bahramali, Mohammad Reza Aghasadeghi, Seyed Mehdi Sadat *
Abstract -   Full Text (PDF)
XML In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii
Samira Sabzi, Farzad Badmasti, Narjes Noori Goodarzi, Mehri Habibi, Shahla Shahbazi, Mohammd Reza Asadi Karam, Mehdi Farokhi *
Abstract -   Full Text (PDF)
XML Evaluation of the Effectiveness of Polyclonal Antibody Developed against a Recombinant Multi-Epitope Protein Composed of Uropathogenic Escherichia coli Antigens
Sheida Hedayat, Mehri Habibi *, Reza Hosseini Doust, Mohammad Reza Asadi Karam
Abstract -   Full Text (PDF)
XML In-Silico Design of a Novel Multi-Epitope Fimbriae Vaccine against Non-typhoidal Salmonella
Babak Beikzadeh *, Shahrzad Ahangarzadeh
Abstract -   Full Text (PDF)
XML Expression of a Novel Fusion Recombinant Protein VP8-VP1 in Escherichia coli as a Rota-HAV Vaccine Candidate
Hassan Yarmohammadi, Abbas Akhavan Sepahi, Mojtaba Hamidi-Fard, Mohammadreza Aghasadeghi *, Golnaz Bahramali
Abstract -   Full Text (PDF)
XML Rabies vaccine: progress and prospective
Mehdi Rahpeyma *, Mohammad Sadeq Khosravy
Abstract -   Full Text (PDF)
XML Which One Should Be Prioritized During Pandemics: Patents or Global Health?
Say-yed Hesameddin Tafreshi *
Abstract -   Full Text (PDF)
Back to Original Issue


© 2024 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.